Insider Stock Trading History of Herberts Curt A. Iii


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Herberts Curt A. Iii since year 2005. The trader's CIK number is 1691262. At the time of this reporting, Herberts Curt A. Iii is the Sr.VP & Chief Business Officer of Sangamo Therapeutics, Inc . (stock ticker symbol SGMO). See this page for all insider trading activities at Sangamo Therapeutics, Inc .


Stock purchases, sales, and option exercises reported by insider Herberts Curt A. Iii since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-12-04 SGMO Sangamo Therapeutics, Inc Sale 11,803 18.00 212,454
2017-12-04 SGMO Sangamo Therapeutics, Inc Option Ex 11,803 12.12 143,052
2017-12-01 SGMO Sangamo Therapeutics, Inc Option Ex 1,197 9.14 10,940
2017-11-30 SGMO Sangamo Therapeutics, Inc Option Ex 13,433 9.41 126,404
2017-12-01 SGMO Sangamo Therapeutics, Inc Sale 3,197 16.70 53,389
2017-11-30 SGMO Sangamo Therapeutics, Inc Sale 13,433 16.00 214,928
2017-10-02 SGMO Sangamo Therapeutics, Inc Option Ex 15,000 7.90 118,455
2017-10-02 SGMO Sangamo Therapeutics, Inc Sale 15,000 15.33 229,995
2017-09-01 SGMO Sangamo Therapeutics, Inc Option Ex 10,316 5.41 55,809
2017-09-01 SGMO Sangamo Therapeutics, Inc Sale 15,000 15.00 225,000
2017-08-14 SGMO Sangamo Therapeutics, Inc Sale 5,000 11.00 55,000
2017-08-11 SGMO Sangamo Therapeutics, Inc Option Ex 6,474 3.27 21,169
2017-08-11 SGMO Sangamo Therapeutics, Inc Sale 6,474 10.00 64,740
2017-08-14 SGMO Sangamo Therapeutics, Inc Option Ex 5,000 5.12 25,600
2017-07-14 SGMO Sangamo Therapeutics, Inc Option Ex 172 3.99 686
2017-07-14 SGMO Sangamo Therapeutics, Inc Sale 15,000 10.00 150,000
2017-06-01 SGMO Sangamo Therapeutics, Inc Sale 2,000 6.80 13,600
2017-05-11 SGMO Sangamo Therapeutics, Inc Sale 639 6.50 4,153
2017-05-12 SGMO Sangamo Therapeutics, Inc Sale 2,000 8.50 17,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Herberts Curt A. Iii (Sr.VP & Chief Business Officer of Sangamo Therapeutics, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.